[46F1-46F1];[46F9-46F9];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
46F1;46F9
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(2R)BSC281.
The presence of P+PBac{XP5.RB3}BSC350 was verified using the PCR methods and primers described in FBrf0175003 with the substitution of the primer 5'-CCAATGCGTTTATTTCAGGTCACG-3'
for the RB3' plus or RB3' minus primer
The cytological breakpoints of Df(2R)BSC350 predicted from the Release 5 genomic coordinates of the P{XP}gemd00231 and PBac{RB}CAPe00006 transposable element insertions sites are 46F1;46F9.